NCT00006368View on ClinicalTrials.gov

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid TumorIslet Cell TumorLung CancerLymphomaMelanoma (Skin)Neoplastic Syndrome
Interventions
RADIATION

yttrium Y 90-edotreotide

Trial Locations (1)

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY